Tacrine

Tacrine is a cholinesterase inhibitor that was used as a medication for the treatment of Alzheimer's disease. It was the first drug approved by the Food and Drug Administration (FDA) for this purpose. Tacrine is known by its brand name, Cognex.
History[edit]
Tacrine was first synthesized in the 1940s and was initially investigated for its potential use in treating myasthenia gravis. However, it was not until the 1980s that its potential for treating Alzheimer's disease was explored. In 1993, Tacrine became the first drug approved by the FDA for the treatment of Alzheimer's disease.
Mechanism of Action[edit]
Tacrine works by inhibiting the enzyme acetylcholinesterase, which breaks down the neurotransmitter acetylcholine. By preventing the breakdown of acetylcholine, Tacrine increases the levels of this neurotransmitter in the brain, which is thought to help alleviate some of the symptoms of Alzheimer's disease.
Pharmacokinetics[edit]
Tacrine is administered orally and is rapidly absorbed from the gastrointestinal tract. It undergoes extensive first-pass metabolism in the liver, primarily by the enzyme cytochrome P450 1A2 (CYP1A2). The drug has a relatively short half-life, necessitating multiple doses throughout the day to maintain therapeutic levels.
Side Effects[edit]
The use of Tacrine is associated with several side effects, the most common of which are gastrointestinal disturbances such as nausea, vomiting, and diarrhea. More serious side effects include hepatotoxicity, which has limited its use. Regular monitoring of liver function tests is required for patients on Tacrine therapy.
Discontinuation[edit]
Due to its side effects and the development of newer cholinesterase inhibitors with better safety profiles, Tacrine has largely fallen out of favor and is no longer widely used. Other drugs such as donepezil, rivastigmine, and galantamine have largely replaced Tacrine in the treatment of Alzheimer's disease.
See Also[edit]
References[edit]
<references group="" responsive="1"></references>
External Links[edit]
Ad. Transform your life with W8MD's Budget GLP-1 injections from $29.99


W8MD offers medical weight loss programs including NYC medical weight loss and Philadelphia medical weight loss offering:
- Affordable GLP1 shots (generic and brand names) such as
- Wegovy NYC (Semaglutide)
- Zepbound NYC /
- Learn more: Budget GLP1 weight loss injections NYC & Philadelphia GLP1 weight loss shots
- Most insurances accepted
- Lowest cost GLP1 weight loss NYC such as Semaglutide starting from $29.99/week and $45.00/week (Tirzepatide) with insurance.
- Prescription weight loss NYC including:
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your physician weight loss journey today at our:
- NYC medical weight loss
- Philadelphia medical weight loss
- Call 718-946-5500 for NYC or 215-676-2334 for Philadelphia
Tags: Budget glp1 weight loss NYC, Zepbound NYC, Philadelphia medical weight loss, Wegovy NYC, Affordable glp1 shots Philadelphia
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian